Dynavox Group AB/Skr DYVOX
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Dynavox Group AB
Dynavox Group AB is a Swedish company that operates in the technology sector, specializing in assistive communication solutions. It provides products and services designed to aid individuals with speech and communication difficulties. The company offers a range of communication devices, software solutions, and related support services. Headquartered in Stockholm, Sweden, Dynavox serves markets around the globe. Its strategic focus is on developing innovative, user-friendly products that enhance the quality of life for people with communication needs.
- Ticker
- Skr DYVOX
- Sector
- Digital Hardware
- Primary listing
- XSTO
- Employees
- 1,107
- Headquarters
- Stockholm, Sweden
- Website
- www.dynavoxgroup.com
Dynavox Group AB Metrics
BasicAdvanced
kr 7.9B
28.42
kr 2.58
0.81
kr 0.50
0.68%
Price and volume
Market cap
kr 7.9B
Beta
0.81
52-week high
kr 105.50
52-week low
kr 57.20
Average daily volume
456K
Dividend rate
kr 0.50
Financial strength
Current ratio
1.713
Quick ratio
1.195
Long term debt to equity
1.193
Total debt to equity
1.328
Dividend payout ratio (TTM)
19.22%
Interest coverage (TTM)
10.84%
Profitability
EBITDA (TTM)
523.1
Gross margin (TTM)
68.66%
Net profit margin (TTM)
10.53%
Operating margin (TTM)
16.31%
Effective tax rate (TTM)
19.22%
Revenue per employee (TTM)
kr 2,370,000
Management effectiveness
Return on assets (TTM)
10.24%
Return on equity (TTM)
40.40%
Valuation
Price to earnings (TTM)
28.421
Price to revenue (TTM)
2.954
Price to book
9.5
Price to tangible book (TTM)
-26.09
Price to free cash flow (TTM)
33.538
Free cash flow yield (TTM)
2.98%
Free cash flow per share (TTM)
2.186
Dividend yield (TTM)
0.68%
Forward dividend yield
0.68%
Growth
Revenue change (TTM)
10.27%
Earnings per share change (TTM)
91.24%
3-year revenue growth (CAGR)
20.35%
3-year earnings per share growth (CAGR)
53.69%
What the Analysts think about Dynavox Group AB
Analyst ratings (Buy, Hold, Sell) for Dynavox Group AB stock.
Analyst projections of the future price of Dynavox Group AB stock.
Bulls say / Bears say
Currency-adjusted revenue rose 15% in the third quarter, with broad-based growth and Germany and Australia among the strongest markets. This points to resilient demand despite delays in parts of the US. (Dynavox Group)
Operating profit increased 87% and the EBIT margin reached 17.4% in Q3, while cash flow after investment more than tripled. The results show that efficiency gains are translating into stronger earnings and cash generation. (Dynavox Group)
The company is integrating acquired European businesses and strengthening local sales execution, with Germany showing promising momentum. A broader direct presence, including the Italian reseller acquisition, could support growth and a more scalable platform. (Dynavox Group, Dynavox Group)
Longer lead times and added administrative checks tied to Medicaid and managed-care funding are holding back US growth. Management expects state-by-state reimbursement complexity to remain a headwind. (Dynavox Group, Investing.com)
Q3 currency-adjusted revenue growth was 15%, below the company’s long-term average growth target of 20%. If growth stays at this slower pace, delivering on that ambition will be harder. (Dynavox Group, Dynavox Group)
Gross margin slipped to 69% from 70% as component costs rose. Further cost increases could erode the benefit of recent operating improvements. (Dynavox Group)
Data summarised monthly by Lightyear AI. Last updated on 22 Oct 2026.
Dynavox Group AB Financial Performance
Revenues and expenses
Dynavox Group AB Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Dynavox Group AB
Fund name | Fund size | Skr DYVOX weighting |
|---|---|---|
iShares Healthcare Innovation£DRDR | $1.3B | 0.08% |
iShares Healthcare Innovation€2B78 | $1.2B | 0.08% |
iShares Healthcare Innovation$HEAL | $1.3B | 0.08% |
iShares Ageing Population$AGED | $953M | 0.07% |
iShares Ageing Population€AGED | $903M | 0.07% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.